I
amDr. ZaferOztas,fromthe Departmentof Ophthalmology,EgeUniversityFacultyofMedicine, Izmir,Turkey.Iwritetopresentasurgicaltechniquereport oftheshort-needleintravitrealinjectiontechnique. Theintravitrealinjectionofanti-vascularendothelialgrowth factor(VEGF)agentshasbecomeapromisingtreatment optionin severalocularpathologiesinvolving neovascularization.Thus,theseinjectionsarethemost frequentvitreoretinalproceduresparticularlyindeveloped countries.Althoughnotconsideredasmajorocularsurgery, thissimpleprocedureisassociatedwithseriousocular complications,suchasendophthalmitis,lensinjury,and retinaldetachment [1] [2] [3] .Therefore,inouropinion,safetyisone ofthemostimportantissuesforintravitrealinjections. Needlesizeisoneofthesignificantfactorsinthesafety issueofintravitrealinjectionprocedure.Previousstudies havesuggestedthattheneedleusedforintravitrealinjection shouldbe1/2to5/8inch(12.7to16mm)inlength,andno largerthan27G [3] [4] [5] .However,duringintravitrealinjection,it isnecessarytoinserttheneedleintothevitreoustoadepth exceeding6mm [4] .Accordingly,anupdatedguidelineforthe intravitrealinjectiontechniquecomposedbyanexpertpanel reportsthatneedlelengthshouldbe5/8inch(18mm)or shorterbutlongenoughtoallowforcompletepenetrationof theparsplana [6] . 
